Torben Michalsen
Chief Operating Officer at G2 GOLDFIELDS INC.
Net worth: 409 020 $ as of 31/05/2024
Network origin in Torben Michalsen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Precious Metals | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Torben Michalsen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GLOBEX MINING ENTERPRISES INC. | Precious Metals | Director of Finance/CFO | |
| PINETREE CAPITAL LTD. | Financial Conglomerates | Director of Finance/CFO | |
| PTX METALS INC. | Precious Metals | Director of Finance/CFO | |
Aranka Gold, Inc.
 Aranka Gold, Inc. Precious MetalsNon-Energy Minerals Part of Zijin Mining Group Co., Ltd., Aranka Gold, Inc. mines for gold. The company is based in Toronto, Canada. Aranka Gold was acquired by Guyana Goldfields, Inc. on January 28, 2009 for $14.40 million. | Precious Metals | President Director/Board Member Director of Finance/CFO | |
| GUYANA GOLDFIELDS INC. | Precious Metals | Founder Director/Board Member Director of Finance/CFO Director/Board Member | |
| SABRE GOLD MINES CORP. | Precious Metals | Director of Finance/CFO | |
| ROYAL STANDARD MINERALS INC. | Precious Metals | Chief Executive Officer | |
| SILVER STORM MINING LTD. | Precious Metals | Director of Finance/CFO | |
| LUMINA GOLD CORP. | Precious Metals | Director/Board Member Director/Board Member | |
| TINTINA MINES LIMITED | Other Metals/Minerals | Director/Board Member | |
| COPPER ROAD RESOURCES INC. | Precious Metals | Corporate Secretary Director of Finance/CFO | |
| DYNACERT INC. | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
The Chartered Governance Institute
 The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| INVENTUS MINING CORP. | Precious Metals | Director of Finance/CFO | |
| BE RESOURCES INC. | Other Metals/Minerals | Director/Board Member Chief Executive Officer | |
| TRANSITION METALS CORP. | Precious Metals | Director of Finance/CFO | |
| DEVERON CORP. | Packaged Software | Director of Finance/CFO | |
| GPM METALS INC. | Other Metals/Minerals | Founder Corporate Secretary Chairman Director of Finance/CFO Director/Board Member | |
| MEGA URANIUM LTD. | Other Metals/Minerals | Director of Finance/CFO | |
| OUTDOORPARTNER MEDIA CORPORATION | Advertising/Marketing Services | Director/Board Member | |
| Institute of Chartered Secretaries & Administrators of Canada | Corporate Officer/Principal | ||
| Marrelli & Drake Corporate Services | Corporate Officer/Principal Corporate Officer/Principal | ||
| REVIVAL GOLD INC. | Precious Metals | Director of Finance/CFO | |
| DSA Corporate Services, Inc. | President Director/Board Member | ||
| MARTINA MINERALS CORP. | Precious Metals | Director of Finance/CFO | |
| NEW FRONTIER VENTURES INC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Revive Therapeutics, Inc.
 Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Pharmaceuticals: Major | Director of Finance/CFO | |
| REVIVE THERAPEUTICS LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
| S2 MINERALS INC. | Other Metals/Minerals | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO Director/Board Member | |
| BLUE LAGOON RESOURCES INC. | Other Metals/Minerals | Director of Finance/CFO | |
| ARANJIN RES | Other Metals/Minerals | Director of Finance/CFO | |
| PHIVIDA HOLDINGS INC. | Pharmaceuticals: Other | Director of Finance/CFO | |
| SINTANA ENERGY INC. | Other Metals/Minerals | Director of Finance/CFO | |
| SKYLIGHT HEALTH GROUP INC. | Medical/Nursing Services | Director of Finance/CFO | |
| OLIVE RESOURCE CAPITAL INC. | Precious Metals | Director of Finance/CFO | |
| AYR WELLNESS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| HIGHROCK RESOURCES LTD. | Oil & Gas Production | Director of Finance/CFO |
Statistics
International
| Canada | 46 |
| United Kingdom | 2 |
| United States | 2 |
Sectoral
| Non-Energy Minerals | 27 |
| Finance | 7 |
| Health Technology | 5 |
| Commercial Services | 4 |
| Producer Manufacturing | 2 |
Operational
| Director of Finance/CFO | 89 |
| Director/Board Member | 38 |
| Corporate Secretary | 33 |
| Corporate Officer/Principal | 19 |
| Independent Dir/Board Member | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Carmelo Marrelli | 107 |
| Shaun Drake | 25 |
| Daniel Noone | 16 |
| Stephen Stow | 8 |
| John Sheridan | 8 |
| Bruce Rosenberg | 5 |
| Boaz Wade | 2 |
- Stock Market
- Insiders
- Torben Michalsen
- Company connections
